Serum markers of fibrosis, cardiovascular and all-cause mortality in hemodialysis patients: the AURORA trial

被引:0
|
作者
Madonna Salib
Sophie Girerd
Nicolas Girerd
Winfried März
Hubert Scharnagl
Ziad A. Massy
Céline Leroy
Kévin Duarte
Hallvard Holdaas
Alan G. Jardine
Roland E. Schmieder
Bengt Fellström
Natalia López-Andrés
Patrick Rossignol
Faiez Zannad
机构
[1] CHRU Nancy; F-CRIN INI-CRCT,Université de Lorraine, Inserm, Centre d’Investigations Cliniques
[2] University Hospital of Nancy,1433, and Inserm U1116
[3] University of Heidelberg,Nephrology Department
[4] Medical University of Graz,Medical Clinic V (Nephrology, Hypertensiology, Rheumatology, Endocrinology, Diabetology), Medical Faculty Mannheim
[5] Paris-Saclay University (PSU) and University of Paris Ouest-Versailles-Saint-Quentin-en-Yvelines (UVSQ),Clinical Institute of Medical and Chemical Laboratory Diagnostics
[6] FCRIN INI-CRCT,Division of Nephrology, Ambroise Paré University Hospital, APHP, Boulogne Billancourt/Paris, and INSERM U
[7] University of Oslo,1018, Centre de recherche en épidémiologie et santé des populations (CESP), Equipe 5
[8] University of Glasgow,Medical Department, Rikshospitalet
[9] University Hospital Erlangen,Renal Research Group, British Heart Foundation Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences
[10] University Hospital,Department of Nephrology and Hypertension
[11] Universidad Pública de Navarra (UPNA),Department of Nephrology
[12] IdiSNA,Navarrabiomed, Complejo Hospitalario de Navarra (CHN)
来源
关键词
Hemodialysis; Collagen; Fibrosis; Biomarker; Galectin-3; Cardiovascular diseases;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:614 / 626
页数:12
相关论文
共 50 条
  • [1] Serum markers of fibrosis, cardiovascular and all-cause mortality in hemodialysis patients: the AURORA trial
    Salib, Madonna
    Girerd, Sophie
    Girerd, Nicolas
    Marz, Winfried
    Scharnagl, Hubert
    Massy, Ziad A.
    Leroy, Celine
    Duarte, Kevin
    Holdaas, Hallvard
    Jardine, Alan G.
    Schmieder, Roland E.
    Fellstrom, Bengt
    Lopez-Andres, Natalia
    Rossignol, Patrick
    Zannad, Faiez
    CLINICAL RESEARCH IN CARDIOLOGY, 2022, 111 (06) : 614 - 626
  • [2] Serum Obestatin: A Biomarker of Cardiovascular and All-Cause Mortality in Hemodialysis Patients
    Beberashvili, Ilia
    Katkov, Anna
    Sinuani, Inna
    Azar, Ada
    Shapiro, Gregory
    Feldman, Leonid
    Gorelik, Oleg
    Stav, Kobi
    Efrati, Shai
    AMERICAN JOURNAL OF NEPHROLOGY, 2018, 47 (04) : 254 - 265
  • [3] There is no association of serum vitamin B levels with all-cause and cardiovascular mortality in hemodialysis patients
    Wang, Yan
    Yang, Bing
    Zhu, Li
    Ni, Meng-fan
    Gan, Liang-ying
    Wang, Mei
    Zuo, Li
    THERAPEUTIC APHERESIS AND DIALYSIS, 2023, 27 (03) : 571 - 579
  • [4] Plasma Cystine Levels and Cardiovascular and All-Cause Mortality in Hemodialysis Patients
    Suzuki, Shota
    Shino, Midori
    Fujikawa, Tetsuya
    Itoh, Yoko
    Ueda, Eiko
    Hashimoto, Tatsuo
    Kuji, Tadashi
    Kobayashi, Naoyuki
    Ohnishi, Toshimasa
    Hirawa, Nobuhito
    Tamura, Kouichi
    Toya, Yoshiyuki
    THERAPEUTIC APHERESIS AND DIALYSIS, 2018, 22 (05) : 476 - 484
  • [5] Association of serum adiponectin levels with all-cause mortality in hemodialysis patients
    Ohashi, Naro
    Kato, Akihiko
    Misaki, Taro
    Sakakima, Masanori
    Fujigaki, Yoshihide
    Yamamoto, Tatsuo
    Hishida, Akira
    INTERNAL MEDICINE, 2008, 47 (06) : 485 - 491
  • [6] Association of serum globulin with all-cause mortality in incident hemodialysis patients
    Pai, Alex Y.
    Sy, John
    Kim, Joseph
    Kleine, Carola-Ellen
    Edward, Jessica
    Hsiung, Jui-Ting
    Kovesdy, Csaba P.
    Kalantar-Zadeh, Kamyar
    Streja, Elani
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (10) : 1993 - 2003
  • [7] IMPACT OF POLYPHARMACY ON ALL-CAUSE MORTALITY, ALL-CAUSE HOSPITALIZATION AND CARDIOVASCULAR EVENTS IN INITIAL JAPANESE HEMODIALYSIS PATIENTS
    Toida, Tatsunori
    Toida, Reiko
    Ebihara, Shou
    Uezono, Shigehiro
    Komatsu, Hiroyuki
    Sato, Yuji
    Fujimoto, Shouichi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1831 - 1831
  • [8] Depression and All-Cause Mortality in Hemodialysis Patients
    Fan, Li
    Sarnak, Mark J.
    Tighiouart, Hocine
    Drew, David A.
    Kantor, Amy L.
    Lou, Kristina V.
    Shaffi, Kamran
    Scott, Tammy M.
    Weiner, Daniel E.
    AMERICAN JOURNAL OF NEPHROLOGY, 2014, 40 (01) : 12 - 18
  • [9] Association of Serum Triglyceride to HDL Cholesterol Ratio with All-Cause and Cardiovascular Mortality in Incident Hemodialysis Patients
    Chang, Tae K.
    Streja, Elani
    Soohoo, Melissa
    Kim, Tae Woo
    Rhee, Connie M.
    Kovesdy, Csaba P.
    Kashyap, Moti L.
    Vaziri, Nosratola D.
    Kalantar-Zadeh, Kamyar
    Moradi, Hamid
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (04): : 591 - 602
  • [10] Association of trimethylamineN-Oxide with cardiovascular and all-cause mortality in hemodialysis patients
    Zhang, Pan
    Zou, Jian-Zhou
    Chen, Jun
    Tan, Xiao
    Xiang, Fang-Fang
    Shen, Bo
    Hu, Jia-Chang
    Wang, Jia-Lin
    Wang, Ya-Qiong
    Yu, Jin-Bo
    Nie, Yu-Xin
    Chen, Xiao-Hong
    Yu, Jia-Wei
    Zhang, Zhen
    Lv, Wen-Lv
    Xie, Ye-Qing
    Cao, Xue-Sen
    Ding, Xiao-Qiang
    RENAL FAILURE, 2020, 42 (01) : 1004 - 1014